Understanding The Role of NCALD in Neurotransmission and Cellular Processes

Target Name: NCALD

NCBI ID: G83988

NCALD

Understanding The Role of NCALD in Neurotransmission and Cellular Processes

Neurocalcin-delta (NCALD) is a protein that is expressed in various tissues throughout the body, including the brain. It is a member of the Calbindin family of proteins, which are involved in cell signaling and cytoskeletal organization. While NCALD has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders, its exact role and mechanisms of action remain poorly understood.

NCALD is involved in a wide range of cellular processes that are essential for normal brain function. One of its most well-known functions is its role in the regulation of cell signaling and neurotransmitter release. NCALD is a critical protein for the regulation of neurotransmitter release from postsynaptic neurons, which is critical for the formation and maintenance of normal neural circuits.

In addition to its role in neurotransmitter release, NCALD is also involved in the regulation of cell adhesion and cytoskeletal organization. It is a critical protein for the regulation of tight junctions, which are a type of cell-cell adhesion that is essential for the integrity of tissues and organs. NCALD is also involved in the regulation of actin cytoskeletal organization, which is important for the proper functioning of cells and tissues.

NCALD has also been identified as a potential drug target and biomarker for a number of psychiatric and neurological disorders. For example, NCALD has been shown to be involved in the pathophysiology of depression, anxiety, and other psychiatric disorders. In addition, NCALD has also been shown to be involved in the pathophysiology of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.

One of the potential mechanisms by which NCALD may contribute to the development and progression of these disorders is its role in the regulation of cellular signaling and neurotransmission. It is possible that disruptions in NCALD function may lead to the misregulation of neurotransmitter signaling and disruptions in cellular signaling pathways that contribute to the development and progression of these disorders.

In addition to its potential role in the regulation of neurotransmission, NCALD is also involved in the regulation of cellular adhesion and cytoskeletal organization, which are important for the proper functioning of cells and tissues. Disruptions in these processes may also contribute to the development and progression of psychiatric and neurological disorders.

Overall, while the exact mechanisms of action and role of NCALD in the regulation of cellular processes are not well understood, its potential as a drug target and biomarker for psychiatric and neurological disorders is an area of ongoing research and study. Further research is needed to fully understand the role of NCALD in the regulation of cellular processes and its potential as a therapeutic target.

Protein Name: Neurocalcin Delta

Functions: May be involved in the calcium-dependent regulation of rhodopsin phosphorylation. Binds three calcium ions

The "NCALD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCALD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets